A new cancer breakthrough could prove to be a gamechanger for preventing the spread of breast cancer to other vital organs ...

The combination therapy failed to beat out the company’s other cancer therapy, Opdivo, in patients living with melanomas.

A research team has developed a multi-medium approach (MMA) to identify reproducible volatile organic compounds (VOCs) in ...

Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...